Third Party Opportunities. Subject to the other sub-paragraphs in this Section 2.8, as part of the Discovery Program, the Parties may evaluate new Targets, Antibodies, and antibody technologies owned or controlled by Third Parties (“Third Party Opportunities”) to determine whether such Targets, Antibodies or antibody technologies should be licensed or acquired by the Parties for the Discovery Program. Should a Party identify such a Third Party Opportunity that it is interested in acquiring or licensing for inclusion in the Discovery Program, it shall notify the other Party for consideration and discussion. If the Parties approve the inclusion of such Third Party Opportunity in the Discovery Program, the Parties shall decide which Party will license or otherwise acquire rights to the Third Party Opportunity and include the applicable Target, Antibody or antibody technology, as the case may be, in the Discovery Program. *********************************************.
Third Party Opportunities. In the event that a party is presented with an opportunity to obtain a license from a Third Party for the development and commercialization of a Small Molecule Compound acting through a Selected Target (a “Third Party Opportunity”), then the party may pursue such Third Party Opportunity, but only in the manner provided in this Section 2.11. For purposes of Third Party Opportunities, Section 2.6.1(a) shall not apply with respect to the parties’ rights and obligations under this Section 2.11 and, accordingly, either party shall have the right to pursue any Third Party Opportunity, and enter into an agreement with a Third Party with respect to such Third Party Opportunity, in accordance with this Section 2.11 provided that Section 2.6.1(b) alone is satisfied.
Third Party Opportunities. 2.9.1 In the event that a Party is presented with an opportunity to collaborate with a Third Party (a “Third Party Opportunity”) with respect to the discovery and/or Pre-Clinical Research Evaluation of one or more Molecules for use [**], then such Party may pursue such Third Party Opportunity, but only in the manner provided in this Section 2.9. Such Party shall present the Third Party Opportunity, including all material terms and conditions relating thereto, to the Joint Research Committee for the Joint Research Committee’s consideration for inclusion in the Research Program.
Third Party Opportunities. Subject to the other sub-paragraphs in this Section 2.8, as part of the Discovery Program, the Parties may evaluate new Targets, Antibodies, and antibody technologies owned or controlled by Third Parties (“Third Party Opportunities”) to determine whether such Targets, Antibodies or antibody technologies should be licensed or acquired by the Parties for the Discovery Program. Should a Party identify such a Third Party Opportunity that it is interested in acquiring or licensing for inclusion in the Discovery Program, it shall notify the other Party for consideration and discussion. If the Parties approve the inclusion of such Third Party Opportunity in the Discovery Program, the Parties shall decide which Party will license or otherwise acquire rights to the Third Party Opportunity and include the applicable Target, Antibody or antibody technology, as the case may be, in the Discovery Program. If the applicable Third Party Opportunity is licensed or acquired ******************************* with respect to the conduct of the Discovery Program as being conducted at the time of such license or acquisition (such licenses being governed by Section 2.18 hereof) *******************************except that, at Regeneron’s option, its share, or a portion of its share, of such costs shall be included in Out-of-Pocket Costs under this Agreement and applied to the calculation of the Maximum Annual Discovery Program Costs for one or more years as the Parties may agree.
Third Party Opportunities. 2.9.1 In the event that a Party is presented with an opportunity to collaborate with a Third Party (a "Third Party Opportunity") with respect to
Third Party Opportunities. (a) TCB shall have the right, at any time and from time to time, to pursue opportunities to license the Global Portal Platform to any third party in any field of use (a "THIRD-PARTY OPPORTUNITY"). In the event that TCB is unable to conclude a definitive agreement within a reasonable time with respect to the Third-Party Opportunity, then TCB shall Notify WWT in writing, describing in reasonable detail such Third-Party Opportunity. Thereafter, WWT shall have the right to seek to obtain a definitive agreement with respect to the Third-Party Opportunity.
Third Party Opportunities. In the event that a party is presented with an opportunity to obtain a license from a Third Party for the development and commercialization of a Small Molecule Compound acting through a Selected Target (a "Third Party Opportunity"), then the party may pursue such Third Party Opportunity, but only in the manner provided in this Section 2.11. For purposes of Third Party Opportunities, Section 2.6.1.(a) shall not apply [**]
Third Party Opportunities. (a) Following the initial six month period from launch of the product, in the event a third party approaches KOOP with a written business proposal whereby the third party will perform the functions to be performed by Licensee under this Agreement with an increase in revenues to KOOP in excess of 25% of the then-current revenues being received by KOOP for the specific product (e.g., as a result of an increase in production, increase in royalties or decrease in costs, etc.), Licensee shall have the right to review, prepare an assessment and match the third party's proposal. Assuming the proposal does not violate the governing principals of the drkoxx.xxx/Xxxxxx xxxiness guidelines and in the event Licensee cannot or refuses to match said proposal or if within a reasonable period of time, KOOP shall have the right to declare the licenses granted hereunder to be non-exclusive and to pursue the business opportunity with the third party.
